Cat. No. 3615
Biological ActivityAngiotensin AT2 receptor agonist (Ki = 7.35 μM) that displays 93-fold selectivity over AT1. Exhibits vasorelaxing and hypotensive activity via activation of the IP (prostacyclin) receptor, and suppresses food intake via activation of PGE2-EP4. Orally active.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Ohinata et al (2009) Orally administered novokinin, an angiotensin AT2 receptor agonist, suppresses food intake via prostaglandin E2-dependent mechanism in mice. Peptides 30 1105. PMID: 19463743.
Yamada et al (2008) A potent hypotensive peptide, novokinin, induces relaxation by AT2- and IP-receptor-dependent mechanism in the mesenteric artery from SHRs. Biosci.Biotechnol.Biochem. 72 257. PMID: 18175894.
Yamada et al (2008) Hypotensive activity of novokinin, a potent analogue of ovokinin(2-7), is mediated by angiotensin AT2 receptor and prostaglandin IP receptor. Peptides 29 412. PMID: 18207609.
If you know of a relevant reference for Novokinin please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Novokinin from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Novokinin, supplier, Orally, active, agonists, Angiotensin, Receptors, AT2, Tocris Bioscience, Angiotensin AT2 Receptor Agonist products